Literature DB >> 25865350

Two-year prospective evaluation of colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: time course and risk factors.

Lea Papst1, Bojana Beović, Katja Seme, Mateja Pirš.   

Abstract

BACKGROUND: We wanted to determine the time course of colonization with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (EPE), sites of colonization and risk factors for prolonged colonization with EPE to obtain information for successful infection control measures.
METHODS: Rectal swab, urine, throat swab and other clinically relevant samples (wound swab, tracheal aspirate and sputum) were obtained from each participant. Sets of follow-up samples and data about potential risk factors for prolonged colonization with EPE were collected every 3 months for 2 years. Multivariate analysis using a logistic regression model was performed to identify risk factors for prolonged colonization.
RESULTS: A total of 114 patients were included in the study, 49 completed the 2-year follow-up. In all, 611 sample sets were collected, 309 (50.6%) of which were positive for ESBL. Of the positive sample sets, 90% had a rectal swab positive for ESBL, the throat swab was positive for ESBL in 17.2% of cases and urine in 36.2% of cases; 10% of positive sample sets had negative rectal swabs with EPE isolated from other sites, most often from urine. Immobility was found to be associated with prolonged carriage (≥ 12 months) of EPE. After 2 years, 15/49 (30.6%) patients were colonized with EPE. In 12/49 (24.5%) patients, transient negativity was observed.
CONCLUSIONS: We found that prolonged colonization with EPE was common, especially in bedridden patients. Transient negative samples were often observed during the course of colonization. In some patients, urine can be the only positive site from which EPE are isolated.

Entities:  

Keywords:  Extended-spectrum beta-lactamases; prolonged colonization; risk factors; sites of colonization

Mesh:

Substances:

Year:  2015        PMID: 25865350     DOI: 10.3109/23744235.2015.1033003

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  5 in total

1.  Multi-Drug-Resistant Gram-Negative Infections in Deployment-Related Trauma Patients.

Authors:  Wesley R Campbell; Ping Li; Timothy J Whitman; Dana M Blyth; Elizabeth R Schnaubelt; Katrin Mende; David R Tribble
Journal:  Surg Infect (Larchmt)       Date:  2017-02-24       Impact factor: 2.150

2.  An outbreak of ertapenem-resistant, carbapenemase-negative and porin-deficient ESBL-producing Klebsiella pneumoniae complex.

Authors:  Mihaela Matovina; Maja Abram; Davorka Repac-Antić; Samira Knežević; Marina Bubonja-Šonje
Journal:  Germs       Date:  2021-06-02

3.  Fecal carriage of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study.

Authors:  Silje B Jørgensen; Arne Søraas; Arnfinn Sundsfjord; Knut Liestøl; Truls M Leegaard; Pål A Jenum
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

4.  Colonization sites in carriers of ESBL-producing Gram-negative bacteria.

Authors:  Joffrey van Prehn; Anna M Kaiser; Suzanne D van der Werff; Rosa van Mansfeld; Christina M J E Vandenbroucke-Grauls
Journal:  Antimicrob Resist Infect Control       Date:  2018-04-12       Impact factor: 4.887

5.  Risk factors associated with prolonged intestinal colonization of ESBL-producing Enterobacteriaceae - a prospective cohort study.

Authors:  Oskar Ljungquist; Marcus Schönbeck; Kristian Riesbeck; Johan Tham
Journal:  Infect Drug Resist       Date:  2019-08-26       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.